Publications
- The effects of three-month intravenous ibandronate on bone mineral density and bone remodeling in klinefelter's syndrome: the influence of vitamin D deficiency and hormonal status2003 | First Faculty of Medicine
- Bone remodeling in drug addictsPublication without faculty affiliation
- Effect of raloxifene on bone mineral density and markers of bone remodeling following alendronate therapyPublication without faculty affiliation
- Growth hormone and bone2006 | First Faculty of Medicine
- Male osteoporosis2006 | First Faculty of Medicine
- No associations between genetic polymorphisms of TGF-beta, PAI-1, and COL1A1, and bone mineral density in caucasian females2006 | First Faculty of Medicine
- The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis2006 | First Faculty of Medicine
- Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study2006 | First Faculty of Medicine
- Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study2006 | First Faculty of Medicine
- Clinical value of the biochemical markers of bone remodeling in the assessment of bone metabolic diseases2006 | First Faculty of Medicine
Loading network view...